JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, S.
Right arrow Articles by Yu, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, S.
Right arrow Articles by Yu, L.

Vol. 286, Issue 1, 136-141, July 1998

Dynorphin A as a Potential Endogenous Ligand for Four Members of the Opioid Receptor Gene Family1

Shengwen Zhang , Yanhe Tong, Mingting Tian, Robert N. Dehaven, Luz Cortesburgos, Erik Mansson, Frédéric Simonin, Brigitte Kieffer and Lei Yu

Department of Medical and Molecular Genetics (S.Z., Y.T., M.T., L.Y.), Walther Oncology Center (L.Y.), Indiana University School of Medicine, Indianapolis, Indiana; Department of Cell Biology, Neurobiology and Anatomy, University of Cincinnati, Ohio (S.Z., L.Y.); Adolor Corporation, Malvern, Pennsylvania (R.N.D., L.C., E.M.) and Ecole Supérieure de Biotechnologie, Parc d'innovation, Bld Sébastien Brand, F-67400 Illkirck, France (F.S., B.K.)

Dynorphin A is an endogenous opioid peptide that activates the kappa opioid receptor (KOR) with high potency. Some studies also showed that the distribution and functional activity of dynorphin A are not completely correlated with those of KOR, suggesting that dynorphin A may interact with other receptors. To investigate the possibility that dynorphin A may serve as an agonist for other opioid receptors, we took the advantage of the cloning of the three major types of opioid receptors, mu (MOR), delta (DOR) and KOR, and examined their affinity for and their activation by dynorphin A. We used mammalian cells transfected with each of the cDNA clones for the human receptors hMOR, hDOR, hKOR and showed that dynorphin A displaced [3H]-diprenorphine binding with Ki values in the nanomolar range at all three receptors. We also showed that, when hMOR, hDOR or hKOR was coexpressed with a G protein-activated potassium channel in Xenopus oocytes, dynorphin A induced a potassium current with EC50 values in the nanomolar range for all three receptors. Furthermore, we showed that the human hORLl, an opioid receptor-like receptor that has been identified as a novel member of the opioid receptor gene family, displayed dynorphin A binding and functional activation. These results indicate that dynorphin A is capable of binding to and functional activation of all members of the opioid receptor family, suggesting that, as a potential endogenous agonist, its activity in humans may involve interaction with other members of the opioid receptor family in addition to kappa receptors.

0022-3565/98/2861-0136$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
H. Xie, J. H. Woods, J. R. Traynor, and M.-C. Ko
The Spinal Antinociceptive Effects of Endomorphins in Rats: Behavioral and G Protein Functional Studies
Anesth. Analg., June 1, 2008; 106(6): 1873 - 1881.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
N. Pinal-Seoane, I. R. Martin, V. Gonzalez-Nunez, E. M. F. de Velasco, F. A. Alvarez, R. G. Sarmiento, and R. E Rodriguez
Characterization of a new duplicate {delta}-opioid receptor from zebrafish
J. Mol. Endocrinol., December 1, 2006; 37(3): 391 - 403.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
V. Gonzalez-Nunez, A. Barrallo, J. R. Traynor, and R. E. Rodriguez
Characterization of Opioid-Binding Sites in Zebrafish Brain
J. Pharmacol. Exp. Ther., February 1, 2006; 316(2): 900 - 904.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Z. Marinova, V. Vukojevic, S. Surcheva, T. Yakovleva, G. Cebers, N. Pasikova, I. Usynin, L. Hugonin, W. Fang, M. Hallberg, et al.
Translocation of Dynorphin Neuropeptides across the Plasma Membrane: A PUTATIVE MECHANISM OF SIGNAL TRANSMISSION
J. Biol. Chem., July 15, 2005; 280(28): 26360 - 26370.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
R. M. Silva, H. C. Grossman, M. M. Hadjimarkou, G. C. Rossi, G. W. Pasternak, and R. J. Bodnar
Dynorphin A1-17-Induced Feeding: Pharmacological Characterization Using Selective Opioid Antagonists and Antisense Probes in Rats
J. Pharmacol. Exp. Ther., May 1, 2002; 301(2): 513 - 518.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
A. Zimmer, E. Valjent, M. Konig, A. M. Zimmer, P. Robledo, H. Hahn, O. Valverde, and R. Maldonado
Absence of Delta -9-Tetrahydrocannabinol Dysphoric Effects in Dynorphin-Deficient Mice
J. Neurosci., December 1, 2001; 21(23): 9499 - 9505.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
E. R. Butelman, T. J. Harris, A. Perez, and M.-J. Kreek
Effects of Systemically Administered Dynorphin A(1-17) in Rhesus Monkeys
J. Pharmacol. Exp. Ther., August 1, 1999; 290(2): 678 - 686.
[Abstract] [Full Text]

Home page
 J. Pharmacol. Exp. Ther.Home page
M. J. Kreek, J. Schluger, L. Borg, M. Gunduz, and A. Ho
Dynorphin A1-13 Causes Elevation of Serum Levels of Prolactin Through an Opioid Receptor Mechanism in Humans: Gender Differences and Implications for Modulation of Dopaminergic Tone in the Treatment of Addictions
J. Pharmacol. Exp. Ther., January 1, 1999; 288(1): 260 - 269.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics.